Vagapova, E.; Kozlov, M.; Lebedev, T.; Ivanenko, K.; Leonova, O.; Popenko, V.; Spirin, P.; Kochetkov, S.; Prassolov, V.
Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. Biomedicines 2021, 9, 1846.
https://doi.org/10.3390/biomedicines9121846
AMA Style
Vagapova E, Kozlov M, Lebedev T, Ivanenko K, Leonova O, Popenko V, Spirin P, Kochetkov S, Prassolov V.
Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. Biomedicines. 2021; 9(12):1846.
https://doi.org/10.3390/biomedicines9121846
Chicago/Turabian Style
Vagapova, Elmira, Maxim Kozlov, Timofey Lebedev, Karina Ivanenko, Olga Leonova, Vladimir Popenko, Pavel Spirin, Sergey Kochetkov, and Vladimir Prassolov.
2021. "Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs" Biomedicines 9, no. 12: 1846.
https://doi.org/10.3390/biomedicines9121846
APA Style
Vagapova, E., Kozlov, M., Lebedev, T., Ivanenko, K., Leonova, O., Popenko, V., Spirin, P., Kochetkov, S., & Prassolov, V.
(2021). Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. Biomedicines, 9(12), 1846.
https://doi.org/10.3390/biomedicines9121846